Rob Knight, PhD 

Leadership Team

1) Dwayne Roach, PhD - March 27, 2019, at UCSD

2) Chip Schooley, MD - April 24, 2019, at SDSU

3) Graham Hatful, PhD - May 29, 2019, at UCSD

4) David Pride, MD PhD - June 26, 2019, at SDSU

5) Katrine Whiteson, PhD - August 28, 2019, at SDSU

6) Vincent Fischetti, PhD - September 25, 2019, at UCSD

7) Justin Meyer, PhD - October 23, 2019, at SDSU

8) Forest Rohwer, PhD - November 20, 2019, at UCSD

9) Paul Bollyky, PhD - January 29, 2020, at SDSU

10) Rob Edwards, PhD - February 26, 2020, at UCSD

11) Kimberly Seed, PhD - April 22, 2020, at UCSD

12) June Round, PhD - June 24, 2020, at UCSD

Leadership Team

Hedieh Attai, PhD  

Postdoctoral Scholar

Connie Benson, MD  

Leadership Team

Chip Schooley, MD 


The Center for Innovative Phage Applications and Therapeutics (IPATH) was founded in the UC San Diego School of Medicine in June 2018 with seed funding from UC San Diego Chancellor Pradeep Khosla. Our goal is to pursue, through collaboration with researchers, companies and institutions around the world, new treatments for combating antimicrobial resistant diseases—focusing on bacteriophage (phage) therapy. We have treated and will continue to treat patients with life-threatening multi-drug resistant infections with phage therapy through the FDA’s compassionate use program.  We also strive to advance phage therapy into clinical trials so that it can be rigorously evaluated and if proven efficacious, become more widely available to combat the global superbug crisis. 

Dwayne Roach, PhD 

Affiliate Member

Research Team

David Pride, MD PhD 

 Leadership Team

Translational Research In Bacteriophage Therapies Seminar Series

Katrine Whiteson, PhD  

Affiliate Member

Lina Huang, BS  

Research Associate

Steffanie Strathdee, PhD 


Saima Aslam, MD 

Leadership Team